Press Room

 

CAPD Statement on New Data Reinforcing that Rebates Do Not Drive High Drug Prices

New research out yesterday from Visante and the Pharmaceutical Care Management Association (PCMA) highlights a seminal point in the…

CAPD Statement on New Report Showing How Pharma Patent Abuses Keep Drug Prices High

A new research report published this month by I-MAK shows how drug companies manipulate the patent and regulatory…

CAPD Statement on CMS Plan to Expand Negotiating Tools in Medicare Advantage

The Coalition for Affordable Prescription Drugs (CAPD), a diverse group of employers, labor unions, pharmacy benefit managers (PBMs),…

CAPD Statement on the Administration’s Forthcoming Rx Rebates Proposal

The Coalition for Affordable Prescription Drugs (CAPD), a diverse group of employers, labor unions, pharmacy benefit managers (PBMs),…

CAPD Statement on FDA Commissioner Gottlieb’s Plans to Spur Generic Competition

The Coalition for Affordable Prescription Drugs (CAPD), a diverse group of employers, labor unions, pharmacy benefit managers (PBMs),…

CAPD Response to the Health and Human Services Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs

  Secretary Alex M. Azar II Department of Health and Human Services 200 Independence Ave. SW, Room 600E…

CAPD Statement for the Record to the Senate Committee on Finance

The Coalition for Affordable Prescription Drugs (CAPD) appreciates the opportunity to submit the following statement for the record. …

CAPD Statement for the Record to the Senate HELP Committee

The Coalition for Affordable Prescription Drugs (CAPD) appreciates the opportunity to submit the following statement for the record. …